Table: begin end state 1 40 signal peptide 41 55 non-cytoplasmic 56 80 transmembrane 81 135 cytoplasmic 136 157 transmembrane 158 173 non-cytoplasmic 174 196 transmembrane 197 226 cytoplasmic 227 245 transmembrane 246 249 non-cytoplasmic 250 267 transmembrane 268 279 cytoplasmic 280 304 transmembrane 305 318 non-cytoplasmic 319 338 transmembrane 339 342 cytoplasmic 343 360 transmembrane 361 372 non-cytoplasmic 373 394 transmembrane 395 405 cytoplasmic 406 427 transmembrane 428 428 non-cytoplasmic
Input: >Pf6N2E2_1038 MLIFLSYAMIASFMYLIMSKRLSPLVALLLVPIVFGCLSGFTTQLGGMMYDGIKMLAPTG IMLTFAILYFCMMTDAGLFNPLIKVLLRLVKGDPRKIVIGTAVLGLCVGLDGDGATTYII ATAAFLPIYRLTGIRLQVMATVLLMAIGVMNILPWAGPFSRAASAMHVDITELFLEMVPV MIAGGVWVIFAAWWLGRMEYRRLGLIAVSEDEVLKGYAHIRLSDPKFLLNVVLTVALISC MMLNLMPLPILFMVAFGLACLVNFPTLKQQKEVIARHADNVMAVTLLIFAAGIFVGIMGG TGMIKAISDNLITLLPQQAGHYMSVITALLSMPFTYVLTNDAFYFGVLPILAETAAHYGI GPNEMAIASLIGQPVHLLSPLVASTYLLCGLLDIDYGDNQRVSLKWTFGTVIVMLFAAIA IGAITVVN
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server